Literature DB >> 29737452

Comparison of Clinical Features and Prognostic Factors of Cryptococcal Meningitis Caused by Cryptococcus neoformans in Patients With and Without Pulmonary Nodules.

Wenhao Cao1, Cui Jian2, Huojun Zhang1, Shuyun Xu3.   

Abstract

Whether the clinical features of cryptococcal meningitis (CM) patients vary with the coexistence of pulmonary nodules is not clear. This study aimed to compare the clinical features of CM in patients with and without pulmonary nodules detected by chest computed tomography (CT). The medical records of CM patients hospitalized in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 1, 2010, to December 31, 2016, were retrospectively reviewed. Baseline demographics, laboratory and radiographic findings, clinical managements, and outcomes were analyzed. A total of 90 CM patients were enrolled. Forty (44.4%) patients had pulmonary nodules (PN-positive), and 50 (55.6%) patients had no pulmonary nodules (PN-negative). Compared with PN-negative patients, PN-positive patients had higher cerebrospinal fluid (CSF)/serum albumin ratios, higher rates of CSF protein > 1000 mg/L, CSF glucose < 2.5 mmol/L, worse overall treatment response, higher rates of abnormal head CT and magnetic resonance imaging manifestations, and more unfavorable clinical outcomes. Multivariate analysis showed that immunocompromise (p = 0.037) and CSF glucose < 2.5 mmol/L (p = 0.044) indicated poor outcome in PN-positive patients, while CSF glucose < 2.5 mmol/L (p = 0.025) also indicated poor outcome in PN-negative patients. Amphotericin B in the initial therapy was a protective factor for PN-negative patients (p = 0.008). Certain clinical features showed significant differences between CM patients with and without pulmonary nodules, and several independent contributing factors impacted the clinical outcomes for CM patients. Future studies should be performed to further examine these factors.

Entities:  

Keywords:  Chest CT; Cryptococcal meningitis; Pulmonary nodules; Unfavorable clinical outcomes

Mesh:

Substances:

Year:  2018        PMID: 29737452     DOI: 10.1007/s11046-018-0263-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  6 in total

1.  Evaluation of cerebrospinal fluid and blood parameters finding in early diagnosis and drug therapy of suspected bacterial meningitis in neonates.

Authors:  Huixian Li; Rui Xiao; Ruheena Javed; Kuanrong Li; Weitao Ye; Wei Zhou; Huiying Liang
Journal:  J Res Med Sci       Date:  2020-08-24       Impact factor: 1.852

2.  Long noncoding RNA expression profile from cryptococcal meningitis patients identifies DPY19L1p1 as a new disease marker.

Authors:  Lei Zhang; Wen-Jie Fang; Ke-Ming Zhang; Wei-Wei Jiang; Min Chen; Wan-Qing Liao; Wei-Hua Pan
Journal:  CNS Neurosci Ther       Date:  2019-02-14       Impact factor: 5.243

3.  Cryptococcal infection in renal transplant: two case reports and a literature review.

Authors:  M D Rojo-Martin; I de Toro Peinado; J D Ruiz Mesa; B Palop Borrás
Journal:  Rev Esp Quimioter       Date:  2021-02-28       Impact factor: 1.553

4.  Clinical Characteristics and Risk Factors for Mortality in Cryptococcal Meningitis: Evidence From a Cohort Study.

Authors:  Fengjuan Wang; Yu Wang; Jianqing He; Zhe Cheng; Shouquan Wu; Minggui Wang; Ting Niu
Journal:  Front Neurol       Date:  2022-04-29       Impact factor: 4.003

5.  Impaired consciousness and decreased glucose concentration of CSF as prognostic factors in immunocompetent patients with cryptococcal meningitis.

Authors:  Chen Zhang; Zheren Tan; Fafa Tian
Journal:  BMC Infect Dis       Date:  2020-01-22       Impact factor: 3.090

Review 6.  Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review.

Authors:  Marhiah C Montoya; Paul M Magwene; John R Perfect
Journal:  J Fungi (Basel)       Date:  2021-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.